Personal exposure to fine particulate matter (PM

Adult Humans Particulate Matter / adverse effects Air Pollutants / adverse effects Environmental Exposure / adverse effects Self Report Air Pollution / adverse effects Asthma / epidemiology
Air pollution Asthma Fine particulate matter Personal exposure Scotland

Journal

Social science & medicine (1982)
ISSN: 1873-5347
Titre abrégé: Soc Sci Med
Pays: England
ID NLM: 8303205

Informations de publication

Date de publication:
Nov 2023
Historique:
received: 06 02 2023
revised: 01 08 2023
accepted: 28 09 2023
medline: 6 11 2023
pubmed: 15 10 2023
entrez: 14 10 2023
Statut: ppublish

Résumé

PM

Identifiants

DOI: 10.1016/j.socscimed.2023.116293 PMID: 37837949
pubmed: 37837949
pii: S0277-9536(23)00650-0
doi: 10.1016/j.socscimed.2023.116293
pii:
doi:

Substances chimiques

Particulate Matter 0
Air Pollutants 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

116293

Informations de copyright

Copyright © 2023 The Authors. Published by Elsevier Ltd.. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest None.

Auteurs

Amy McCarron (A)

Biological and Environmental Sciences, University of Stirling, FK9 4LA, UK. Electronic address: amy.mccarron@stir.ac.uk.

Sean Semple (S)

Institute for Social Marketing and Health, University of Stirling, FK9 4LA, UK. Electronic address: sean.semple@stir.ac.uk.

Christine F Braban (CF)

UK Centre for Ecology and Hydrology (UKCEH), Penicuik, EH26 0QB, UK. Electronic address: chri2@ceh.ac.uk.

Colin Gillespie (C)

Scottish Environment Protection Agency (SEPA), Stirling, FK9 4TZ, UK. Electronic address: colin.gillespie@sepa.org.uk.

Vivien Swanson (V)

Psychology, University of Stirling, FK9 4LA, UK. Electronic address: vivien.swanson@stir.ac.uk.

Heather D Price (HD)

Biological and Environmental Sciences, University of Stirling, FK9 4LA, UK. Electronic address: heather.price@stir.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Personal exposure to fine particulate matter (PM
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Personal exposure to fine particulate matter (PM
questionsmedicales.fr › Mélanges complexes › Matière particulaire › Personal exposure to fine particulate matter (PM
questionsmedicales.fr › Actions chimiques et utilisations › Actions toxiques › Polluants environnementaux › Polluants atmosphériques › Personal exposure to fine particulate matter (PM
questionsmedicales.fr › Environnement et santé publique › Santé publique › Pollution de l'environnement › Exposition environnementale › Personal exposure to fine particulate matter (PM
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Collecte de données › Enquêtes et questionnaires › Autorapport › Personal exposure to fine particulate matter (PM
questionsmedicales.fr › Environnement et santé publique › Santé publique › Pollution de l'environnement › Pollution de l'air › Personal exposure to fine particulate matter (PM
questionsmedicales.fr › Maladies du système immunitaire › Hypersensibilité › Hypersensibilité immédiate › Hypersensibilité respiratoire › Asthme › Personal exposure to fine particulate matter (PM